UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019056
Receipt number R000022027
Scientific Title Research for the relation between urinary L-FABP and CKD progression
Date of disclosure of the study information 2015/10/02
Last modified on 2016/09/20 00:50:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research for the relation between urinary L-FABP and CKD progression

Acronym

Urinary L-FABP and CKD progression

Scientific Title

Research for the relation between urinary L-FABP and CKD progression

Scientific Title:Acronym

Urinary L-FABP and CKD progression

Region

Japan


Condition

Condition

Chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To predict the progression of CKD by urinary L-FABP

Basic objectives2

Others

Basic objectives -Others

Relation between the etiology of CKD and urinary L-FABP

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between the change of eGFR in the past one year and urinary L-FABP

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Single measurement of urinary L-FABP

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Non-dialysis CKD patients followed for more than one year in our hospital

Key exclusion criteria

CKD patients who developed to AKI during past one year

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideaki Oka

Organization

Matsuyama redcross hospital

Division name

Kidney center

Zip code


Address

1 Bunkyocho, Matsuyama

TEL

089-924-1111

Email

okanokao@matsuyama.jrc.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideaki Oka

Organization

Matsuyama redcross hospital

Division name

Kidney center

Zip code


Address

1 Bunkyocho, Matsuyama

TEL

089-924-1111

Homepage URL


Email

okanokao@matsuyama.jrc.or.jp


Sponsor or person

Institute

Matsuyama redcross hospital

Institute

Department

Personal name



Funding Source

Organization

Matsuyama redcross hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

This study demonstrated a moderate correlation between the slope of eGFR and L-FABP. However, the correlation between urine protein and slope of eGFR was stronger than that of L-FABP and additional prognostic value of L-FABP to urine protein could not be showen.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 07 Day

Last follow-up date

2015 Year 10 Month 31 Day

Date of closure to data entry

2015 Year 11 Month 14 Day

Date trial data considered complete

2015 Year 11 Month 14 Day

Date analysis concluded

2015 Year 11 Month 14 Day


Other

Other related information



Management information

Registered date

2015 Year 09 Month 17 Day

Last modified on

2016 Year 09 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022027


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name